Holen Sie sich die Stockscreener-App
89.16
0.32%
0.28
Vorhandelsmarkt:
89.24
0.08
+0.09%
Schlusskurs vom Vortag:
$88.88
Offen:
$88.5
24-Stunden-Volumen:
341.15K
Relative Volume:
0.80
Marktkapitalisierung:
$907.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.51%
1M Leistung:
+5.49%
6M Leistung:
-4.79%
1J Leistung:
-10.33%
1-Tages-Spanne:
$88.50
$89.25
1-Wochen-Bereich:
$88.13
$89.32
52-Wochen-Spanne:
$77.67
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Firmenname
Vaneck Pharmaceutical Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
89.16 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
315.99 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
640.27 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
643.42 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
251.20 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
565.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Aktie (PPH) Neueste Nachrichten
Pharma stocks higher as Trump backs down from 250% tariff threat - Seeking Alpha
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - The Globe and Mail
LPL Financial LLC Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - The Globe and Mail
Markets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff Blitz - Money Morning
Envestnet Asset Management Inc. Reduces Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Cetera Investment Advisers Has $3.16 Million Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - NewsBreak: Local News & Alerts
J&J leads big pharma higher after earnings despite Trump’s latest tariff threat - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
ETFs To Gain On JNJ's Solid Q1 Earnings & Upbeat Outlook - Barchart.com
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again - Seeking Alpha
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And Center (PPH) - Seeking Alpha
Janney Montgomery Scott LLC Cuts Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Innovative Industrial Properties (NYSE:IIPR) Rating Lowered to Peer Perform at Wolfe Research - Defense World
Janney Montgomery Scott LLC Takes $448,000 Position in PUTNAM MAST INT (NYSE:PIM) - Defense World
Morgan Stanley Forecasts Strong Price Appreciation for ICL Group (NYSE:ICL) Stock - Defense World
Stifel Nicolaus Begins Coverage on Jabil (NYSE:JBL) - Defense World
Eaton Vance Enhanced Equity Income Fund II (NYSEARCA:EOS) Shares Sold by Cambridge Investment Research Advisors Inc. - Defense World
Petroleo Brasileiro S.A.- Petrobras (NYSE:PBR) Shares Sold by Janney Montgomery Scott LLC - Defense World
Microsoft Corporation (NASDAQ:MSFT) Shares Acquired by Fermata Advisors LLC - Defense World
PPH's Dividend Surge: A Healthcare Income Play in Volatile Markets - AInvest
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' - Benzinga
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Global pharma stocks down as Trump renews tariff threat - MSN
Short bets on S&P 500 Healthcare sector ease in May; MRNA stays most shorted stock - Seeking Alpha
Millennium Management LLC Lowers Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Trump says pharma tariffs are coming in the “not-too-distant-future” - MSN
Ameriprise Financial Inc. Sells 3,806 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
Innovator Growth-100 Power Buffer ETF – September (NYSEARCA:NSEP) Holdings Lifted by Jane Street Group LLC - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Trims Stake in Vanguard S&P 500 Value ETF (NYSEARCA:VOOV) - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Stake Raised by Bank of America Corp DE - Defense World
Bank of America Corp DE Purchases 1,732 Shares of VanEck Retail ETF (NASDAQ:RTH) - Defense World
Gilead and Vertex Pharma named among biotech’s tariff safe havens - MSN
Finanzdaten der Vaneck Pharmaceutical Etf-Aktie (PPH)
Es liegen keine Finanzdaten für Vaneck Pharmaceutical Etf (PPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):